Literature DB >> 1310601

A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells.

C R Gandhi1, K Stephenson, M S Olson.   

Abstract

Endothelin-3 (ET-3) stimulated phosphoinositide metabolism and synthesis of prostaglandins in cultured rat Kupffer cells. ET-3-induced hydrolysis of phosphoinositides was characterized by the production of various inositol phosphates and of glycerophosphoinositol. The mechanism of ET-3-stimulated metabolism of phosphoinositides and synthesis of prostaglandins appeared to be distinct from the effect of platelet-activating factor (PAF) on these processes described previously [Gandhi, Hanahan & Olson (1990) J. Biol. Chem. 265, 18234-18241]. On a molar basis ET-3 was significantly more potent than PAF in stimulating phosphoinositide metabolism, e.g. ET-3-induced hydrolysis of phosphoinositides occurred at 1 pM, whereas PAF was ineffective at concentrations less than 1 nM. Upon challenging Kupffer cells with both ET-3 and PAF, an additive stimulation of phosphoinositide metabolism was observed, suggesting that the actions of these factors may be exerted on separate phosphoinositide pools. Treatment of Kupffer cells with pertussis toxin resulted in an inhibition of ET-3-induced phospholipase C activation; in contrast, cholera toxin treatment caused potentiation of ET-3-stimulated phospholipase C activity. Both toxins, however, inhibited PAF-stimulated phospholipase C activity. The present results suggest that the stimulatory effects of ET-3 and PAF on the phosphodiesteric metabolism of phosphoinositides in Kupffer cells require different guanine-nucleotide-binding proteins. Furthermore, the effects of bacterial toxins on ET-3- and PAF-induced phosphoinositide metabolism were not mediated by cyclic AMP. ET-3-induced metabolism of phosphoinositides was inhibited completely in Kupffer cells pretreated with ET-3, suggesting homologous ligand-induced desensitization of the ET-3 receptors. In contrast, similar experiments using PAF showed only a partial desensitization of subsequent PAF-induced phosphoinositide metabolism. In contrast to the increased production of prostaglandins E2 and D2 observed upon stimulation of Kupffer cells with PAF, ET-3 stimulated the biosynthesis of prostaglandin E2 only. Consistent with their additive effects on phosphoinositide metabolism, PAF and ET-3 exhibited an additive stimulation of the synthesis of prostaglandin E2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310601      PMCID: PMC1130711          DOI: 10.1042/bj2810485

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

1.  Endothelin, a potent peptide agonist in the liver.

Authors:  C R Gandhi; K Stephenson; M S Olson
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

2.  Cellular signaling by peptides of the endothelin gene family.

Authors:  M S Simonson; M J Dunn
Journal:  FASEB J       Date:  1990-09       Impact factor: 5.191

Review 3.  Prostaglandins and thromboxanes.

Authors:  B Samuelsson; M Goldyne; E Granström; M Hamberg; S Hammarström; C Malmsten
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  Elimination of intravenously injected endothelin-1 from the circulation of the rat.

Authors:  R Shiba; M Yanagisawa; T Miyauchi; Y Ishii; S Kimura; Y Uchiyama; T Masaki; K Goto
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

5.  Inositol 1,4,5-trisphosphate and inositol 1,3,4-trisphosphate formation in Ca2+-mobilizing-hormone-activated cells.

Authors:  G M Burgess; J S McKinney; R F Irvine; J W Putney
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

6.  Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilization.

Authors:  P A Marsden; N R Danthuluri; B M Brenner; B J Ballermann; T A Brock
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

7.  Comparative studies of phosphoinositide hydrolysis induced by endothelin-related peptides in cultured cerebellar astrocytes, C6-glioma and cerebellar granule cells.

Authors:  W W Lin; C Y Lee; D M Chuang
Journal:  Biochem Biophys Res Commun       Date:  1990-04-30       Impact factor: 3.575

8.  Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells.

Authors:  P Vigne; R Marsault; J P Breittmayer; C Frelin
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

9.  ET-1 receptors in C-6 cells: homologous down-regulation and modulation by protein kinase C.

Authors:  E N Cozza; M C Vila; C E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  1990-04-17       Impact factor: 4.102

10.  Endothelin stimulates inositol phosphate accumulation in rat right and left atria: a comparison with noradrenaline.

Authors:  I J Kuraja; E A Woodcock
Journal:  Clin Exp Pharmacol Physiol       Date:  1990-04       Impact factor: 2.557

View more
  12 in total

1.  A synthetic selective inhibitor of factor Xa, DX-9065a, reduces monocyte chemoattractant protein-1 expression after ischemia-reperfusion injury in rat liver.

Authors:  Y Yamaguchi; K Okabe; J Liang; F Matsumura; H Ohshiro; K Ishihara; T Matsuda; M Takeya; J I Kuratsu; K Mori; S Yamada; M Ogawa
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  Augmenter of liver regeneration promotes hepatocyte proliferation induced by Kupffer cells.

Authors:  Chun-Ping Wang; Lin Zhou; Shu-Hui Su; Yan Chen; Yin-Ying Lu; Fei Wang; Hong-Jun Jia; Yong-Yi Feng; Yong-Ping Yang
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

3.  A fresh look at augmenter of liver regeneration in rats.

Authors:  C R Gandhi; R Kuddus; V M Subbotin; J Prelich; N Murase; A S Rao; M A Nalesnik; S C Watkins; A DeLeo; M Trucco; T E Starzl
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

4.  Action of endothelins on hepatic stellate cells.

Authors:  N Kawada; T Kuroki; K Kobayashi; M Inoue; K Kaneda; K Decker
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

5.  Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors.

Authors:  A Mallat; A M Préaux; C Serradeil-Le Gal; D Raufaste; C Gallois; D A Brenner; C Bradham; J Maclouf; V Iourgenko; L Fouassier; D Dhumeaux; P Mavier; S Lotersztajn
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

6.  Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway.

Authors:  A Mallat; L Fouassier; A M Préaux; C S Gal; D Raufaste; J Rosenbaum; D Dhumeaux; C Jouneaux; P Mavier; S Lotersztajn
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis.

Authors:  Yin-Ying Lu; Chun-Ping Wang; Lin Zhou; Yan Chen; Shu-Hui Su; Yong-Yi Feng; Yong-Ping Yang
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  Differential expression of platelet-activating factor acetylhydrolase in lung macrophages.

Authors:  Katherine M Howard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

9.  Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes.

Authors:  C R Gandhi; R H Behal; S A Harvey; T A Nouchi; M S Olson
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

10.  Hepatic stellate cells may be potential effectors of platelet activating factor induced portal hypertension.

Authors:  Yan Chen; Chun-Ping Wang; Yin-Ying Lu; Lin Zhou; Shu-Hui Su; Hong-Jun Jia; Yong-Yi Feng; Yong-Ping Yang
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.